Taiwania Capital is a venture capital firm founded in August 2017 by the National Development Fund of the Executive Yuan of Taiwan and private enterprises. The firm focuses on investing in disruptive technology and biotech startups that are based in Taiwan or the US. Taiwania Capital typically participates in various investment stages, including Seed, Series A, Series B, and beyond, supporting companies with advanced and innovative technologies.
Notable portfolio companies include AEye, Ambiq Micro, Arris, and Landing AI, which have collectively raised significant capital. Key partners at Taiwania Capital bring extensive experience from both public and private sectors, enhancing their ability to identify and nurture high-potential startups. The firm's investment philosophy centers on fostering technological advancements to boost Taiwan's economic growth. Taiwania Capital also offers unique value-add services such as strategic guidance, industry connections, and support in scaling operations globally.
Taiwania Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Taiwania Capital, a venture capital firm, invests in disruptive tech and biotech startups to boost Taiwan's economy.
Stage Mix
Concentration shown as share of disclosed investments by stage.
Darwin Venture Management
darwinventures.com
Tyche Partners
tychepartners.com
Taiwan Global Angels
Cornerstone Ventures
cornerstonevc.tw
TaiAn Technologies
Taifu Capital
WK Technology Fund
Matoka Capital
matokacapital.com
PTI Ventures
Trans-Pacific Technology Fund
tptf.co
Tapas Capital
tapas.capital
TSC Bioventure Capital
Industrial Technology Investment
itic.com.tw
Taihill Venture
taihill.vc
Taiho Ventures
taihoventures.com
